Karin Jirström
301 – 310 of 352
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Modeling Prognostic Markers in Breast Cancer — Are We Using Them the Optimal Way?
Strand, C ; Falck, A-K ; Jirström, K LU
; Malmström, P
LU
; Rydén, L
LU
; Bendahl, P-O
LU
and Fernö, M.
LU
(2010)
In Cancer Research
70(24 Supplement).
- Contribution to journal › Published meeting abstract
- 2009
-
Mark
The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancer
Brennan, Donal ; Ek, Sara LU
; Doyle, Emma
; Drew, Thomas
; Foley, Michael
; Flannelly, Grainne
; O´Conner, Darren P
; Gallagher, William M
; Kilpinen, Sami
and Kallioniemi, Olli-Pekka
, et al.
(2009)
In European Journal of Cancer
45(8).
p.1510-1517
- Contribution to journal › Article
-
Mark
Prognostic Significance of Stromal Platelet-Derived Growth Factor beta-Receptor Expression in Human Breast Cancer
Paulsson, Janna ; Sjoblom, Tobias ; Micke, Patrick ; Ponten, Fredrik ; Landberg, Goran ; Heldin, Carl-Henrik ; Bergh, Jonas ; Brennan, Donal J. ; Jirström, Karin LU
and Ostman, Arne
(2009)
In American Journal of Pathology
175(1).
p.334-341
- Contribution to journal › Article
-
Mark
Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer
Lanigan, Fiona ; McKiernan, Eadaoin ; Brennan, Donal J. ; Hegarty, Shauna ; Millikan, Robert C. ; McBryan, Jean ; Jirström, Karin LU
; Landberg, Göran
LU
; Martin, Finian
and Duffy, Michael J.
, et al.
(2009)
In International Journal of Cancer
124(9).
p.2088-2097
- Contribution to journal › Article
-
Mark
JAM-A expression positively correlates with poor prognosis in breast cancer patients
McSherry, Elaine A. ; McGee, Sharon F. ; Jirström, Karin LU
; Doyle, Emma M.
; Brennan, Donal J.
; Landberg, Göran
LU
; Dervan, Peter A.
; Hopkins, Ann M.
and Gallagher, William M.
(2009)
In International Journal of Cancer
125(6).
p.1343-1351
- Contribution to journal › Article
-
Mark
Differential expression of cytoplasmic and stromal beta-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
Lundgren, Katja LU ; Jirström, Karin LU
and Landberg, Göran
LU
(2009)
8th Madrid Breast Cancer Conference
In Breast Cancer Research
11.
p.15-15
- Contribution to journal › Published meeting abstract
-
Mark
Vascular endothelial growth factor receptor 2 is a significant negative prognostic biomarker in triple-negative breast cancer: results from a controlled randomised trial of premenopausal breast cancer
Rydén, Lisa LU
; Fernö, Mårten
LU
; Stal, O
; Linderholm, B.
; Ostman, A
and Jirström, Karin
LU
(2009)
31st Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(2).
p.132-132
- Contribution to journal › Published meeting abstract
-
Mark
DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT
Dolan, R. T. ; Brennan, D. J. ; Rexhepaj, E. ; Kelly, C. M. ; Penny, S. ; Jirström, Karin LU
; Ponten, F.
; Uhlen, M.
and Gallagher, W. M.
(2009)
IMPAKT Breast Cancer Conference 2009
In Annals of Oncology
20(Suppl 2).
p.54-54
- Contribution to journal › Published meeting abstract
-
Mark
Long-Term Survival of Breast Ductal Carcinoma In Situ in Women with Different Gene-Expression Types.
Zhou, W. ; Johansson, C. ; Jirström, Karin LU
; Olorunsola, A.
; Garmo, H.
and Warnberg, F.
(2009)
32nd Annual San Antonio Breast Cancer Symposium
In Cancer Research
69(24).
p.629-630
- Contribution to journal › Published meeting abstract
-
Mark
The Prognostic Significance of Tryptophanyl-tRNA Synthetase in Colorectal Cancer
Ghanipour, Arezo ; Jirström, Karin LU
; Ponten, Fredrik
; Glimelius, Bengt
; Pahlman, Lars
and Birgisson, Helgi
(2009)
In Cancer Epidemiology Biomarkers & Prevention
18(11).
p.2949-2956
- Contribution to journal › Article